The impact of squamous and glandular differentiation on survival after radical cystectomy for urothelial carcinoma.

[1]  D. E. Mills,et al.  Sternberg's Diagnostic Surgical Pathology , 2012 .

[2]  F. Montorsi,et al.  Survival after radical cystectomy of non‐bilharzial squamous cell carcinoma vs urothelial carcinoma: a competing‐risks analysis , 2012, BJU international.

[3]  S. Ohara,et al.  Desmocollin 2 is a new immunohistochemical marker indicative of squamous differentiation in urothelial carcinoma , 2011, Histopathology.

[4]  E. Messing,et al.  DO MIXED HISTOLOGICAL FEATURES AFFECT SURVIVAL BENEFIT FROM NEOADJUVANT PLATINUM‐BASED COMBINATION CHEMOTHERAPY IN PATIENTS WITH LOCALLY ADVANCED BLADDER CANCER? , 2011, BJU international.

[5]  W. Lowrance,et al.  Comparative outcomes of pure squamous cell carcinoma and urothelial carcinoma with squamous differentiation in patients treated with radical cystectomy. , 2011, The Journal of urology.

[6]  E. Messing,et al.  Do mixed histological features affect survival benefit from neoadjuvant platinum‐based combination chemotherapy in patients with locally advanced bladder cancer? A secondary analysis of Southwest Oncology Group‐Directed Intergroup Study (S8710) , 2010, BJU international.

[7]  F. Montorsi,et al.  Adenocarcinoma versus urothelial carcinoma of the urinary bladder: comparison between pathologic stage at radical cystectomy and cancer-specific mortality. , 2010, Urology.

[8]  T. Braun,et al.  Urothelial carcinoma with divergent histologic differentiation (mixed histologic features) predicts the presence of locally advanced bladder cancer when detected at transurethral resection. , 2007, Urology.

[9]  M. Srougi,et al.  The role of squamous differentiation in patients with transitional cell carcinoma of the bladder treated with radical cystectomy. , 2007, International braz j urol : official journal of the Brazilian Society of Urology.

[10]  H. Wiśniewska,et al.  Muscle-invasive urothelial cell carcinoma of the human bladder: multidirectional differentiation and ability to metastasize. , 2007, Human pathology.

[11]  Liang Cheng,et al.  Histologic variants of urothelial carcinoma: differential diagnosis and clinical implications. , 2006, Human pathology.

[12]  M. Dimopoulos,et al.  The outcome of patients with advanced pure squamous or mixed squamous and transitional urothelial carcinomas following platinum-based chemotherapy. , 2006, Anticancer research.

[13]  R. Montironi,et al.  Squamous differentiation in primary urothelial carcinoma of the urinary tract as seen by MAC387 immunohistochemistry , 2006, Journal of Clinical Pathology.

[14]  Y. Lotan,et al.  Clinical outcomes following radical cystectomy for primary nontransitional cell carcinoma of the bladder compared to transitional cell carcinoma of the bladder. , 2006, The Journal of urology.

[15]  S. Suster,et al.  High-grade urothelial carcinoma of the renal pelvis: clinicopathologic study of 108 cases with emphasis on unusual morphologic variants , 2006, Modern Pathology.

[16]  Z. Wolski,et al.  Usefulness of histologic homogeneity estimation of muscle-invasive urinary bladder cancer in an individual prognosis: a mapping study. , 2005, Urology.

[17]  Yair Lotan,et al.  Lymphovascular Invasion Is Independently Associated With Overall Survival, Cause-Specific Survival, and Local and Distant Recurrence in Patients With Negative Lymph Nodes at Radical Cystectomy , 2005 .

[18]  Ryan P. McCarthy,et al.  Tumorigenesis and Neoplastic Progression Molecular Genetic Evidence for a Common Clonal Origin of Urinary Bladder Small Cell Carcinoma and Coexisting Urothelial Carcinoma , 2005 .

[19]  N. Masumori,et al.  Local recurrence after radical cystectomy for invasive bladder cancer: an analysis of predictive factors. , 2004, Urology.

[20]  W. Murphy,et al.  Tumors of the kidney, bladder, and related urinary structures , 2004 .

[21]  M. Lisanti,et al.  Expression of caveolin-1 and caveolin-2 in urothelial carcinoma of the urinary bladder correlates with tumor grade and squamous differentiation. , 2003, American journal of clinical pathology.

[22]  E. Kunze,et al.  Histogenesis of nonurothelial carcinomas of the urinary bladder from pre-existent transitional cell carcinomas. A histopathological and immunohistochemical study , 2002, Urological Research.

[23]  R. Start.  AFIP Atlas of Tumor Pathology , 2000 .

[24]  T. Ørntoft,et al.  Proteomics and immunohistochemistry define some of the steps involved in the squamous differentiation of the bladder transitional epithelium: a novel strategy for identifying metaplastic lesions. , 1999, Cancer research.

[25]  R. Dodge,et al.  The value of pathologic factors in predicting cancer‐specific survival among patients treated with radical cystectomy for transitional cell carcinoma of the bladder and prostate , 1993, Cancer.

[26]  M. Tsuneyoshi,et al.  Urinary bladder carcinoma with a neoplastic squamous component: a mapping study of 31 cases , 1992, Histopathology.

[27]  J. Martin,et al.  Clinical importance of squamous metaplasia in invasive transitional cell carcinoma of the bladder. , 1989, Journal of clinical pathology.

[28]  C. Dinney,et al.  The impact of variant histology on the outcome of bladder cancer treated with curative intent. , 2009, Urologic oncology.

[29]  A. Billis,et al.  Squamous and/or glandular differentiation in urothelial carcinoma: Prevalence and significance in transurethral resections of the bladder , 2004, International Urology and Nephrology.

[30]  C. Logothetis,et al.  Cisplatin, cyclophosphamide and doxorubicin chemotherapy for unresectable urothelial tumors: the M.D. Anderson experience. , 1989, The Journal of urology.